Navigate to
-
Drug Approvals Monthly Update: March 2024 Traditional New drugs 3/04/2024 clobetasol propionate 0.05% The FDA approved the first clobetasol propionate ophthalmic formulations. The 0.05% suspension...
-
PUBLICATIONS FDA Decisions Expected: August 2025 Your monthly synopsis of new drugs expected to hit the market All brand names are property of their respective owners. References Press release:...
-
In the latest episode of the “Pharmacy Friends” podcast, hear from Prime Therapeutics experts about how the fast-moving pipeline is changing how patients, providers and payers prepare for...
PA Sub-Categories: Specialty drugs Prime Article: Stories -
Polaris is awaiting an FDA decision for pegargiminase, an arginine degrading enzyme, for the treatment of malignant pleural mesothelioma (MPM) with non-epithelioid histology. The FDA granted the...
-
-
Learn with Biosimilar Basics. Part 1 starts with an overview of biosimilar products, sharing what biosimilar drugs are and the difference vs generic drugs.
PA Sub-Categories: Specialty drugs Prime Article: Perspectives -
Journal of Managed Care & Specialty Pharmacy (JMCP)
PA Sub-Categories: GLP-1 Prime Article: In the News -
Unlock high-touch outreach Help members and their prescribers make better decisions about medicines through this clinical intelligence hub that delivers actionable insights, flexible levels of data...
-
In the latest episode of the “Pharmacy Friends” podcast, hear more about what faster drug decisions could mean for evidence review, affordability assessment and implementation planning
PA Sub-Categories: Specialty drugs Prime Article: Stories -
From research posters and education sessions to the Pharmacy Friends podcast, Prime has you covered on the latest managed care pharmacy insights
PA Sub-Categories: Awards GLP-1 Specialty drugs Technology Prime Article: Stories -
Prime Therapeutics clinical experts shared insights on the specialty drug pipeline at recent industry event
PA Sub-Categories: Specialty drugs Prime Article: Stories -
A roundup of Prime's award-winning presentations and insights at AMCP Annual Meeting in Houston
PA Sub-Categories: Awards GLP-1 Technology Prime Article: Stories -
In the latest episode of the “Pharmacy Friends” podcast, join Prime’s research team for a preview of the industry-leading and award-winning research that will be presented at flagship industry event
PA Sub-Categories: GLP-1 Specialty drugs Prime Article: Stories -
Studies include Prime’s GLP-1 obesity research and a Medicare drug cost predictive model
Prime Article: Research & Publications PA Research & Publications: Research posters & abstracts -
Learn with Biosimilar Basics. Part 2 covers biosimilar naming conventions and other nomenclature including common drug pipeline content acronyms.
PA Sub-Categories: Specialty drugs Prime Article: Perspectives -
In this episode, Prime/MRx clinicians — along with special guests — discuss the hottest topics covered at the Academy of Managed Care Pharmacy (AMCP)'s 2024 Annual Meeting in New Orleans
PA Sub-Categories: GLP-1 Specialty drugs Prime Article: Stories -
Managed Healthcare Executive
PA Sub-Categories: GLP-1 Prime Article: In the News -
USA Today
PA Sub-Categories: GLP-1 Prime Article: In the News -
Reuters
PA Sub-Categories: GLP-1 Prime Article: In the News -
Insider
PA Sub-Categories: GLP-1 Prime Article: In the News